InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Smith Devin Whittemore, SVP et Conseiller Juridique Général. Director active across 2 companies, notably Yumanity Therapeutics, INC.. Aggregated, 5 filings have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €18k. History available since 1 December 2021. The latest transaction was filed on 23 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations
Devin Whittemore Smith is the SVP and General Counsel at YUMANITY THERAPEUTICS, INC. He oversees all legal matters for the company, including regulatory compliance and litigation. His role is crucial in ensuring the protection of the company's legal interests while supporting its strategic objectives. He works closely with management to navigate the complex legal landscape of the biopharmaceutical industry.